BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21394035)

  • 1. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
    Vigneault P; Kaddar N; Bourgault S; Caillier B; Pilote S; Patoine D; Simard C; Drolet B
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):690-5. PubMed ID: 21394035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration.
    Vigneault P; Pilote S; Patoine D; Simard C; Drolet B
    Pharmacol Res; 2012 Jul; 66(1):60-5. PubMed ID: 22465688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galantamine (Reminyl) delays cardiac ventricular repolarization and prolongs the QT interval by blocking the HERG current.
    Vigneault P; Bourgault S; Kaddar N; Caillier B; Pilote S; Patoine D; Simard C; Drolet B
    Eur J Pharmacol; 2012 Apr; 681(1-3):68-74. PubMed ID: 22366430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tizanidine (Zanaflex): a muscle relaxant that may prolong the QT interval by blocking IKr.
    Kaddar N; Vigneault P; Pilote S; Patoine D; Simard C; Drolet B
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):102-9. PubMed ID: 21317414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic probucol treatment decreases the slow component of the delayed-rectifier potassium current in CHO cells transfected with KCNQ1 and KCNE1: a novel mechanism of QT prolongation.
    Taniguchi T; Uesugi M; Arai T; Yoshinaga T; Miyamoto N; Sawada K
    J Cardiovasc Pharmacol; 2012 Apr; 59(4):377-86. PubMed ID: 22189896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
    Hough DW; Gopal S; Coppola D; Remmerie BM; Berwaerts J; Nuamah IF; Sterkens PC; Xu Y
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):298-9. PubMed ID: 22410947
    [No Abstract]   [Full Text] [Related]  

  • 8. Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current.
    Geelen P; Drolet B; Rail J; Bérubé J; Daleau P; Rousseau G; Cardinal R; O'Hara GE; Turgeon J
    Circulation; 2000 Jul; 102(3):275-7. PubMed ID: 10899088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
    Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
    Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current.
    Drolet B; Yang T; Daleau P; Roden DM; Turgeon J
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):934-7. PubMed ID: 12775973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
    Yasuda C; Yasuda S; Yamashita H; Okada J; Hisada T; Sugiura S
    J Physiol Pharmacol; 2015 Aug; 66(4):599-607. PubMed ID: 26348084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective estrogen receptor modulator raloxifene inhibits cardiac delayed rectifier potassium currents and voltage-gated sodium current without QTc interval prolongation.
    Liu H; Yang L; Jin MW; Sun HY; Huang Y; Li GR
    Pharmacol Res; 2010 Nov; 62(5):384-90. PubMed ID: 20674746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.
    Kongsamut S; Kang J; Chen XL; Roehr J; Rampe D
    Eur J Pharmacol; 2002 Aug; 450(1):37-41. PubMed ID: 12176106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin Causes a Novel Proarrhythmic Syndrome.
    Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKF-96365 blocks human ether-à-go-go-related gene potassium channels stably expressed in HEK 293 cells.
    Liu H; Yang L; Chen KH; Sun HY; Jin MW; Xiao GS; Wang Y; Li GR
    Pharmacol Res; 2016 Feb; 104():61-9. PubMed ID: 26689773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current.
    Morissette P; Hreiche R; Mallet L; Vo D; Knaus EE; Turgeon J
    J Psychopharmacol; 2007 Sep; 21(7):735-41. PubMed ID: 17092964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure.
    Watanabe E; Yasui K; Kamiya K; Yamaguchi T; Sakuma I; Honjo H; Ozaki Y; Morimoto S; Hishida H; Kodama I
    Circ J; 2007 Apr; 71(4):471-8. PubMed ID: 17384445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estradiol on cardiac ion channel currents.
    Möller C; Netzer R
    Eur J Pharmacol; 2006 Feb; 532(1-2):44-9. PubMed ID: 16480714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
    El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
    J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
    Melgari D; Brack KE; Zhang C; Zhang Y; El Harchi A; Mitcheson JS; Dempsey CE; Ng GA; Hancox JC
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25911606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.